These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 38794321)

  • 1. Review of the Existing Translational Pharmacokinetics Modeling Approaches Specific to Monoclonal Antibodies (mAbs) to Support the First-In-Human (FIH) Dose Selection.
    Pasquiers B; Benamara S; Felices M; Nguyen L; Declèves X
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule.
    Hosseini I; Fleisher B; Getz J; Decalf J; Kwong M; Ovacik M; Bainbridge TW; Moussion C; Rao GK; Gadkar K; Kamath AV; Ramanujan S
    Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonistic TAM-163 antibody targeting tyrosine kinase receptor-B: applying mechanistic modeling to enable preclinical to clinical translation and guide clinical trial design.
    Vugmeyster Y; Rohde C; Perreault M; Gimeno RE; Singh P
    MAbs; 2013; 5(3):373-83. PubMed ID: 23529133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.
    Yadav R; Schubbert S; Holder PG; Chiang EY; Kiabi N; Bogaert L; Leung I; Rashid R; Avery KN; Bonzon C; Desjarlais JR; Sanjabi S; Sharma A; Lepherd M; Shelton A; Chan P; Liu Y; Joslyn L; Hosseini I; Stefanich EG; Kamath AV; Bernett MJ; Shivva V
    Front Pharmacol; 2024; 15():1380000. PubMed ID: 38887559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical pharmacokinetics, pharmacodynamics and safety assessment of a FLT3L-Fc molecule for cancer immunotherapy.
    Wu KC; Adedeji AO; Zabka TS; Hosseini I; Kenkre R; Getz JA; Nguyen T; Decalf J; Bainbridge TW; Chilton JA; Moussion CC; Rao GK
    Toxicol Appl Pharmacol; 2024 Feb; 483():116837. PubMed ID: 38278496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex PK-PD of an engineered IL-15/IL-15Rα-Fc fusion protein in cynomolgus monkeys: QSP modeling of lymphocyte dynamics.
    Lu D; Yadav R; Holder P; Chiang E; Sanjabi S; Poon V; Bernett M; Varma R; Liu K; Leung I; Bogaert L; Desjarlais J; Shivva V; Hosseini I; Ramanujan S
    Eur J Pharm Sci; 2023 Jul; 186():106450. PubMed ID: 37084985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD141
    Lee YS; O'Brien LJ; Walpole CM; Pearson FE; Leal-Rojas IM; Masterman KA; Atkinson V; Barbour A; Radford KJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s.
    Oba T; Long MD; Keler T; Marsh HC; Minderman H; Abrams SI; Liu S; Ito F
    Nat Commun; 2020 Oct; 11(1):5415. PubMed ID: 33110069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.
    Mayoux M; Roller A; Pulko V; Sammicheli S; Chen S; Sum E; Jost C; Fransen MF; Buser RB; Kowanetz M; Rommel K; Matos I; Colombetti S; Belousov A; Karanikas V; Ossendorp F; Hegde PS; Chen DS; Umana P; Perro M; Klein C; Xu W
    Sci Transl Med; 2020 Mar; 12(534):. PubMed ID: 32161104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.
    Satyamitra M; Cary L; Dunn D; Holmes-Hampton GP; Thomas LJ; Ghosh SP
    Sci Rep; 2020 Feb; 10(1):1757. PubMed ID: 32019942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function.
    Lee JH; Choi SY; Jung NC; Song JY; Seo HG; Lee HS; Lim DS
    J Cancer; 2020; 11(4):769-775. PubMed ID: 31949478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell subsets and locations.
    Balan S; Saxena M; Bhardwaj N
    Int Rev Cell Mol Biol; 2019; 348():1-68. PubMed ID: 31810551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in cancer immunology and immunotherapy.
    Wculek SK; Cueto FJ; Mujal AM; Melero I; Krummel MF; Sancho D
    Nat Rev Immunol; 2020 Jan; 20(1):7-24. PubMed ID: 31467405
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.